Actualités et vidéos - Business Wire

Vonage (NewVoiceMedia) has been positioned by Gartner, Inc. in the Leaders and Visionaries quadrant of the Magic Quadrant for Contact Center as a Service (CCaaS), for Western Europe and North America, respectively. For the former, this marks the third consecutive year Vonage’s NewVoiceMedia solution has been recognised as a Leader. Gartner’s Magic Quadrants objectively depict the vendor landscape in various technology sectors. Vendors are assessed against strict criteria and those who appear...

Regulatory News: Total (Paris:FP) (LSE:TTA) (NYSE:TOT) has signed a shareholders’ agreement with Chinese state-owned Zhejiang Energy Group (ZEG), to create a joint venture company dedicated to the supply and delivery of marine fuels in the region of Zhoushan, China. The agreement, signed on the sidelines of the IPEC conference in Zhoushan, follows a Memorandum of Understanding concluded by Total and ZEG in April 2019 to explore opportunities in the supply and distribution of energy in China....

Regulatory News: Total (Paris:FP) (LSE:TTA) (NYSE:TOT) a signé un accord avec la compagnie publique chinoise Zhejiang Energy Group (ZEG), afin d’établir dans la région de Zhoushan une coentreprise dédiée à l’approvisionnement et à la fourniture de carburants marins. Cet accord, signé à l’occasion de l’International Petroleum and Natural Gas Enterprises Conference (IPEC 2019) se tenant à Zhoushan, s’inscrit dans la continuité du protocole d’accord conclu en avril 2019 par...

Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), pionnier des solutions d’imagerie 2D / 3D et de données pour l’orthopédie, a annoncé aujourd’hui les premiers cas patients ayant bénéficié d’une planification chirurgicale réalisée avec son logiciel hipEOS 3.0 et transférée en per-opératoire au système de navigation Intellijoint HIP d’Intellijoint Surgical qui permet un guidage du geste chirurgical par des mesures de...

Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, today announced the first patient cases performed with its hipEOS 3.0 surgical planning software delivered intraoperatively by Intellijoint HIP®, Intellijoint Surgical’s smart navigation system, which offers surgeon-controlled surgical guidance for intraoperative positional...

Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced results from a retrospective chart review study (EVOLVE), which investigated the likelihood of serious adverse events and serious infections with vedolizumab and anti-tumor necrosis factor-alpha (anti-TNFα) therapies in biologic-naïve patients with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD) in real-world clinical practice. These data were announced in an oral...

Regulatory News: GENOMIC VISION (Paris:GV) (FR0011799907 – GV), a biotechnology company developing molecular and Artificial Intelligence tools to control quality and safety of genetically modified genome, announced today promising results from its strategic research partnership with the Children’s Medical Research Institute (CMRI, Sydney) with the purpose of understanding the effects of telomere length on complex diseases, notably cardiovascular diseases and cancers. Telomeres are regions in...

Sartorius, ein international führender Partner der biopharmazeutischen Forschung und Industrie, hat sich auch im dritten Quartal dynamisch entwickelt und in der Neun-Monats-Periode zweistellige Steigerungsraten bei Umsatz, Auftragseingang und Ertrag erzielt. „Sartorius hat auch für die ersten neun Monate des Jahres deutlich zweistellige Wachstumsraten bei Umsatz und Gewinn erzielt”, sagte Konzernchef Dr. Joachim Kreuzburg. „Unsere Sparte Lab Products & Services hat in einem weltweit...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III IMbrave150 study, evaluating Tecentriq ® (atezolizumab) in combination with Avastin ® (bevacizumab) as a treatment for people with unresectable hepatocellular carcinoma (HCC) who have not received prior systemic therapy, met both of its co-primary endpoints demonstrating statistically significant and clinically meaningful improvements in overall survival (OS) and progression-free survival...

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191020005071/en/ (Graphic: Business Wire) ABIVAX SA (Paris:ABVX) (Euronext Paris: FR0012333284 – ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, announced today new data showing that 75% of the patients were in clinical remission after a 12-month open-label oral...

Regulatory News: Ce communiqué de presse contient des éléments multimédias. Voir le communiqué complet ici : https://www.businesswire.com/news/home/20191020005072/fr/ (Graphic: Business Wire) ABIVAX SA (Paris:ABVX) (Euronext Paris : FR0012333284 – ABVX), société de biotechnologie au stade clinique qui mobilise le système immunitaire afin de développer de nouveaux traitements contre les maladies inflammatoires, les maladies virales et le cancer, annonce aujourd’hui qu’après 12...

Regulatory News: Sartorius Stedim Biotech (SSB) (Paris:DIM) has agreed to acquire parts of Danaher’s Life Science portfolio as part of a broader transaction between Danaher and Sartorius Group, SSB’s major shareholder. The total purchase price is approximately $750 million in cash of which about a quarter will be allocated to the businesses purchased by SSB. The final purchase price allocation will be subject to the closing process. The businesses to be acquired by SSB had combined sales...

Oggi, il principale scambio di criptovaluta bitFlyer ha annunciato il lancio dell'app bitFlyer in Europa e negli Stati Uniti. L'app, disponibile gratuitamente su iOS e Android, consentirà agli utenti di acquistare e vendere Bitcoin (BTC), Ethereum (ETH), Litecoin (LTC), Bitcoin Cash (BCH), Ethereum Classic (ETC), Monacoin (MONA) e Lisk (LSK). 1 questo comunicato stampa include contenuti multimediali. Visualizzare l’intero comunicato qui:...

Regulatory News: Sartorius Stedim Biotech (SSB) (Paris:DIM), fournisseur majeur de l’industrie biopharmaceutique, poursuit sa croissance avec une hausse à deux chiffres de son chiffre d’affaires, ses prises de commandes et son résultat au cours des neuf premiers mois de l’exercice 2019. « Suite à un premier semestre plus positif que prévu, la croissance s’est maintenue au troisième trimestre. Nous profitons de la demande élevée soutenue dans toutes les régions et catégories de...

Regulatory News: Sartorius Stedim Biotech (SSB) (Paris:DIM), a leading partner of the biopharma industry, has continued on its growth track, and reported a double-digit increase in sales revenue, order intake and earnings for the first nine months of 2019. “After a stronger-than-expected first half, growth momentum remained high in the third quarter. We have been benefiting from ongoing high demand across all regions and product categories and, beyond this, have continued to grow faster than...

Sartorius, ein führender Partner der biopharmazeutischen Industrie und Forschung, hat eine Vereinbarung über den Erwerb von Teilen des Life-Science-Portfolios von Danaher für rund 750 Millionen US-Dollar in bar unterzeichnet. Das zum Kauf stehende Portfolio erzielte 2018 einen Gesamtumsatz von rund 140 Millionen US-Dollar bei zweistelligen operativen Gewinnmargen sowie starkem Wachstumsprofil und beschäftigt weltweit rund 300 Mitarbeiter. Die geplante Transaktion wird voraussichtlich im...

Aujourd’hui, la plate-forme leader d’échange de crypto-monnaies bitFlyer annonce le lancement de l’application bitFlyer en Europe et aux États-Unis . L’application, disponible gratuitement sur iOS et Android, va permettre aux utilisateurs d’acheter et de vendre des Bitcoin (BTC), Ethereum (ETH), Litecoin (LTC), Bitcoin Cash (BCH), Ethereum Classic (ETC), Monacoin (MONA) et Lisk (LSK). 1 Ce communiqué de presse contient des éléments multimédias. Voir le communiqué complet ici :...

Regulatory News: Sartorius Stedim Biotech (SSB) (Paris:DIM) s’engage d'acquérir une partie du portefeuille des sciences de la vie de Danaher dans le cadre d'une transaction plus large entre Danaher et Sartorius Group, le principal actionnaire de SSB. Le prix d'achat total est d'environ 750 millions de dollars en espèces, dont environ un quart sera attribuée aux activités acquises par SSB. La répartition finale du prix d'achat sera assujettie au processus de finalisation de l’opération....

Sartorius, a leading international partner of biopharmaceutical research and the industry, performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the year as well,” said Executive Board Chairman and CEO Dr. Joachim Kreuzburg. “In a challenging global economic environment,...

Sartorius, a leading partner to the biopharmaceutical industry and laboratories, has signed an agreement to acquire parts of Danaher’s Life Science portfolio for approximately $750 million in cash. The businesses had combined sales turnover of approximately $140 million in 2018 with a strong growth profile and double-digit profit margins. They employ around 300 people worldwide. The proposed transaction is expected to be completed in the first quarter of 2020 and is subject to customary...